Literature DB >> 26643945

Care and viral suppression during the last year of life among persons with HIV who died in 2012, 18 US jurisdictions.

H Irene Hall1, Lorena Espinoza1, Shericka Harris2, Jing Shi2.   

Abstract

Death due to HIV remains a leading cause of death among some US populations, yet little is known about HIV care before death. We used data from the National HIV Surveillance System to determine disease stage and care within 12 months prior to death among persons infected with HIV who died in 2012. Persons were considered to be in care within 12 months before death if they had ≥1 CD4 or viral load test results, and in continuous care if they had ≥2 CD4 or viral load test results at least 3 months apart. Viral suppression (viral load <200 copies/mL) was based on the most recent viral load test result in the 12 months before death. Among 7348 persons infected with HIV who died in 2012, 47.1% had late stage disease (AIDS) within 12 months before death. Overall, 85.7% had ≥1 test result, 64.3% had ≥2 tests at least 3 months apart, and 41.6% had a suppressed viral load. While blacks and Hispanics/Latinos had higher percentages of continuous care compared with whites, they had lower percentages of viral suppression and higher percentages with late stage disease. Viral suppression was higher among older persons. The majority had been diagnosed with HIV more than 5 years before death (86.3%). Although the majority of persons infected with HIV who died in 2012 had been diagnosed many years before death, almost half had late stage disease, and there were disparities in late stage disease and viral suppression by race/ethnicity and age.

Entities:  

Keywords:  AIDS; HIV; care; death; treatment

Mesh:

Substances:

Year:  2015        PMID: 26643945      PMCID: PMC8669830          DOI: 10.1080/09540121.2015.1118428

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  14 in total

1.  Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates.

Authors:  N A Hessol; S P Buchbinder; D Colbert; S Scheer; R Underwood; J L Barnhart; P M O'Malley; L S Doll; A R Lifson
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

2.  Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.

Authors:  Patricia Sweeney; Lytt I Gardner; Kate Buchacz; Pamela Morse Garland; Michael J Mugavero; Jeffrey T Bosshart; R Luke Shouse; Jeanne Bertolli
Journal:  Milbank Q       Date:  2013-07-08       Impact factor: 4.911

3.  The future of HIV prevention in the United States.

Authors:  Jonathan Mermin; Kevin A Fenton
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

4.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

5.  Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women?

Authors:  Amy Rock Wohl; Frank H Galvan; Hector F Myers; Wendy Garland; Sheba George; Mallory Witt; Joseph Cadden; Eva Operskalski; Wilbert Jordan; Felix Carpio; Martin L Lee
Journal:  AIDS Behav       Date:  2011-08

Review 6.  Retaining HIV-infected patients in care: Where are we? Where do we go from here?

Authors:  Elizabeth Horstmann; Jillian Brown; Fareesa Islam; Johanna Buck; Bruce D Agins
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

7.  Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

8.  Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Authors:  Frank J Palella; Carl Armon; Kate Buchacz; Joan S Chmiel; Richard M Novak; Richard T D'Aquila; John T Brooks
Journal:  J Antimicrob Chemother       Date:  2014-06-16       Impact factor: 5.790

9.  Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Authors:  H Irene Hall; Emma L Frazier; Philip Rhodes; David R Holtgrave; Carolyn Furlow-Parmley; Tian Tang; Kristen Mahle Gray; Stacy M Cohen; Jonathan Mermin; Jacek Skarbinski
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

10.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  2 in total

1.  Factors Associated with State Variation in Mortality Among Persons Living with Diagnosed HIV Infection.

Authors:  Amy L Krueger; Michelle Van Handel; Patricia M Dietz; Weston O Williams; Anna Satcher Johnson; Pamela W Klein; Stacy Cohen; Paul Mandsager; Laura W Cheever; Philip Rhodes; David W Purcell
Journal:  J Community Health       Date:  2019-10

2.  HIV Care and Viral Suppression During the Last Year of Life: A Comparison of HIV-Infected Persons Who Died of HIV-Attributable Causes With Persons Who Died of Other Causes in 2012 in 13 US Jurisdictions.

Authors:  William K Adih; H Irene Hall; Richard M Selik; Xiuchan Guo
Journal:  JMIR Public Health Surveill       Date:  2017-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.